Metabolically-inactive glucagon-like peptide-1(9–36)amide confers selective protective actions against post-myocardial infarction remodelling
出版年份 2016 全文链接
标题
Metabolically-inactive glucagon-like peptide-1(9–36)amide confers selective protective actions against post-myocardial infarction remodelling
作者
关键词
Glucagon-like peptide-1 (GLP-1), GLP-1(9–36)amide, Myocardial infarction, Cardiac remodelling
出版物
Cardiovascular Diabetology
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-04-15
DOI
10.1186/s12933-016-0386-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts
- (2016) Jianfeng Du et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages
- (2015) Mitchel Tate et al. BASIC RESEARCH IN CARDIOLOGY
- Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix
- (2015) Emma Robinson et al. BASIC RESEARCH IN CARDIOLOGY
- Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation
- (2015) Yue Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inflammation in cardiac injury, repair and regeneration
- (2015) Nikolaos G. Frangogiannis CURRENT OPINION IN CARDIOLOGY
- GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice
- (2015) Eva Tomas et al. DIABETES
- GLP-1 Cleavage Product Reverses Persistent ROS Generation After Transient Hyperglycemia by Disrupting an ROS-Generating Feedback Loop
- (2015) Ferdinando Giacco et al. DIABETES
- Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat–Fed Diabetic Mice
- (2015) Erin E. Mulvihill et al. DIABETES
- Effect of Glucagon-like Peptide-1 on High-Glucose-induced Oxidative Stress and Cell Apoptosis in Human Endothelial Cells and Its Underlying Mechanism
- (2015) Rehua Wang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium
- (2014) Megan DeNicola et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Glucagon-like peptide-1 (7–36) but not (9–36) augments cardiac output during myocardial ischemia via a Frank–Starling mechanism
- (2014) Adam G. Goodwill et al. BASIC RESEARCH IN CARDIOLOGY
- Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction
- (2014) Vasundhara Kain et al. BASIC RESEARCH IN CARDIOLOGY
- Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes
- (2014) Mitchel Tate et al. BRITISH JOURNAL OF PHARMACOLOGY
- Exendin-4 ameliorates cardiac ischemia/reperfusion injury via caveolae and caveolins-3
- (2014) Yasuo M Tsutsumi et al. Cardiovascular Diabetology
- GLP-1 (7–36) amide restores myocardial insulin sensitivity and prevents the progression of heart failure in senescent beagles
- (2014) Melissa Chen et al. Cardiovascular Diabetology
- Molecular mechanisms of diabetic cardiomyopathy
- (2014) Heiko Bugger et al. DIABETOLOGIA
- Effects of Glucagon-like Peptide-1 in Diabetic Rat Small Resistance Arteries
- (2014) Zeliha Bayram et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection
- (2014) John R. Ussher et al. Molecular Metabolism
- Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a
- (2013) Craig W. Younce et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Macrophage MicroRNA-155 Promotes Cardiac Hypertrophy and Failure
- (2013) Stephane Heymans et al. CIRCULATION
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Matrix metalloproteinase (MMP)-9: A proximal biomarker for cardiac remodeling and a distal biomarker for inflammation
- (2013) Ganesh V. Halade et al. PHARMACOLOGY & THERAPEUTICS
- Glucagon-Like Peptide-1(9-36) Inhibits Chemokine-Induced Migration of Human CD4-Positive Lymphocytes
- (2013) Ana Liberman et al. PLoS One
- Glucagon-Like Peptide-1 Cleavage Product GLP-1(9-36) Amide Rescues Synaptic Plasticity and Memory Deficits in Alzheimer's Disease Model Mice
- (2012) T. Ma et al. JOURNAL OF NEUROSCIENCE
- Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
- (2010) Y. Zhao et al. CANCER RESEARCH
- Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure
- (2010) Que Liu et al. Cardiovascular Diabetology
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice
- (2010) M. Sauve et al. DIABETES
- Glucagon-Like Peptide (GLP)-1(9-36)Amide-Mediated Cytoprotection Is Blocked by Exendin(9-39) Yet Does Not Require the Known GLP-1 Receptor
- (2010) Kiwon Ban et al. ENDOCRINOLOGY
- Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?
- (2009) David J Grieve et al. BRITISH JOURNAL OF PHARMACOLOGY
- GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
- (2009) M. H. Noyan-Ashraf et al. DIABETES
- Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction
- (2009) C. Troidl et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cardiac fibroblasts: At the heart of myocardial remodeling
- (2009) Karen E. Porter et al. PHARMACOLOGY & THERAPEUTICS
- GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP
- (2008) Brian D. Green et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
- (2008) Kiwon Ban et al. CIRCULATION
- Chronic Glucagon-Like Peptide-1 Infusion Sustains Left Ventricular Systolic Function and Prolongs Survival in the Spontaneously Hypertensive, Heart Failure–Prone Rat
- (2008) Indu Poornima et al. Circulation-Heart Failure
- Involvement of Nox2 NADPH Oxidase in Adverse Cardiac Remodeling After Myocardial Infarction
- (2008) Yee H. Looi et al. HYPERTENSION
- Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia–reperfusion injury in rat heart
- (2007) David P. Sonne et al. REGULATORY PEPTIDES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started